3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Multiple Myeloma
15
Myelodysplastic Syndromes
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Hematologic Neoplasms
5
Myeloproliferative Disorders
4
Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Neuroblastoma
3
Neoplasm, Residual
3
Leukemia, Myelomonocytic, Juvenile
3
Graft vs Host Disease
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Precancerous Conditions
2
Neoplasms, Plasma Cell
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Immunoblastic Lymphadenopathy
2
Interventions
Injections
3
Cytarabine
3
pegylated granulocyte colony-stimulating factor
2
Decitabine
2
Daunorubicin
2
Cladribine
2
Biopsy
2
Azacitidine
2
venetoclax
1
ruxolitinib
1
fludarabine phosphate
1
fedratinib
1
enasidenib
1
Whole-Body Irradiation
1
Tacrolimus
1
Spinal Puncture
1
Specimen Handling
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mitoxantrone
1
Liposomes
1
Gemtuzumab
1
Cyclophosphamide
1
CPX-351
1
Bone Marrow Transplantation
1
2'-chloro-2'-deoxyadenosine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Monocytic, Acute
×
Melphalan
×
90 days
×
Clear all
No trials found.